In an exclusive conversation with Deccan Chronicle, Dr. G Vikram Kumar sheds light on the complexities of hemophilia, its impact on patients’ lives, and the recent breakthroughs in the ...

Join this channel to get access to perks: <a href="https://www.youtube.com/channel/UC-NDC9sjHn3I5Qo99Uf4IvA/join">https://www.youtube.com/channel/UC ...

Like any other disease, hemophilia also has its signs and symptoms. Hemophilia symptoms may present for the first time during any scheduled surgery. • Excessive external bleeding that may first ...

Researchers reviewed data from 14 hemophilia patients treated with Sevenfact to better understand its real-world safety and ...

The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

Females can also be affected but tend to have milder symptoms. People with mild hemophilia A may have prolonged bleeding events after a surgical procedure, dental work, or a serious injury.

Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...

for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A (congenital factor VIII deficiency ...

Standard of care for hemophilia B is episodic intravenous ... Current prophylactic therapies do not provide a cure, eliminate symptoms, or prevent joint damage. Other non-factor IX agents that ...

The Food and Drug Administration approved Pfizer’sPFE-0.17%decrease; red down pointing triangle Hympavzi to prevent or reduce bleeding episodes in patients with certain kinds of hemophilia ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ ...

Fidanacogene elaparvovec, an adeno-associated virus (AAV) gene-therapy vector for hemophilia B containing a high-activity human factor IX variant (FIX-R338L/FIX-Padua), was associated with ...